Jan 04, 2012 9:15am EST

Immunovaccine Vaccinates First Patient in Phase I Trial of the DPX-Survivac Cancer Vaccine

Oct 17, 2011 8:07am EDT

Immunovaccine Appoints Wayne Pisano to its Board

Sep 23, 2011 5:30pm EDT

Immunovaccine Announces CEO Start Date, Grant of Options and Amendments to its Stock Option Plan

Sep 12, 2011 8:30am EDT

Immunovaccine Announces Appointment of John Trizzino as CEO

Aug 24, 2011 8:15am EDT

Immunovaccine Announces 2011 Second Quarter Results

Jun 22, 2011 5:35pm EDT

Immunovaccine Announces 2011 First Quarter Results

Jun 20, 2011 8:35am EDT

FDA Approves Immunovaccine's Application for a Phase I/II Clinical Trial for an Ovarian Cancer Vaccine

Jun 16, 2011 9:00am EDT

Immunovaccine Nominates Brad Thompson for Appointment to the Board

Jun 14, 2011 9:55am EDT

2011 Warwick Kimmins Science Scholarship Awarded

Jun 01, 2011 8:32am EDT

Immunovaccine Announces Immune Results from Phase I Trial for DPX-0907 Therapeutic Cancer Vaccine